Diabetic kidney disease: from physiology to therapeutics - Wikidata - awgldk - TriplyDB

Diabetic kidney disease: from physiology to therapeutics

Diabetic kidney disease: from physiology to therapeutics

http://www.wikidata.org/entity/Q27021392

about

Soy-based renoprotection Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats Morning blood pressure surge and target organ damage in newly diagnosed type 2 diabetic patients: a cross sectional study.HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.Additive Effect of Qidan Dihuang Grain, a Traditional Chinese Medicine, and Angiotensin Receptor Blockers on Albuminuria Levels in Patients with Diabetic Nephropathy: A Randomized, Parallel-Controlled Trial.Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years.Management of glycemia in diabetic patients with stage IV and V chronic kidney disease.Glucose Homeostasis and Cardiovascular Alterations in Diabetes.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Cellular senescence in renal ageing and disease.Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease Cardiovascular complications of type 2 diabetes in youth.Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy Advances in Chronic Kidney Disease.Association of elevated frequency of micronuclei in peripheral blood lymphocytes of type 2 diabetes patients with nephropathy complications.Glycyrrhizic Acid Prevents Diabetic Nephropathy by Activating AMPK/SIRT1/PGC-1α Signaling in db/db Mice.T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal.MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.Src Homology 2 Domain-Containing Inositol 5'-Phosphatase Ameliorates High Glucose-Induced Extracellular Matrix Deposition via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Renal Tubular Epithelial Cells.A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF rats.Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.

P2860

Q26751544-72A1CB4F-6955-4F8E-9C35-676B07BF8071 Q28552591-43AFDAC8-253A-4C7E-AF26-4AF08019AFEC Q30238531-16D68A56-8A00-49E7-B3C3-5DA69D6540C1 Q35852316-6478F141-70D6-4B66-9131-DBDD9D532E7E Q35859398-F5233FC8-95E7-4C20-8E4F-97DAA0B1DE1C Q36820740-500CF14D-35A8-4ED4-BF44-BB473FD54B99 Q37027123-E202D791-5B06-48D1-8F4E-0AB03D75E597 Q37588847-664D57CF-D855-4060-9DA1-A0DE474D0404 Q37727230-C4191F95-3325-458C-8041-D67ADD2E2D22 Q38378755-70E08354-F282-433A-9DB4-9E9BDCACD0CD Q38596700-D06A35D3-356A-4556-B193-01060B0514F2 Q38942962-9C5926B3-5FB6-4F0B-ACB1-9949F8C2CA56 Q39060497-A3A514E1-B6DD-4AE6-9A5C-FE44DBDF666C Q41452150-8C0BF238-D712-4678-BB06-A39C41CA3BE8 Q41514778-136E7856-231A-4FD7-A285-459379E03280 Q42352782-CA740577-FC36-4ABD-9B34-C347BDA50CA6 Q42401109-F218D227-3031-45CC-8D2D-7724CF27D156 Q42495174-909EAF06-ABBD-40EA-8518-5C906246EC66 Q46241564-72FC6740-5BD3-4ED4-BA53-7C3CAAAB28F4 Q47093542-F6A39DEA-8239-49ED-9918-31EAF4CC350B Q47115045-4A831BC5-B1DE-4B6A-8905-A7A9D04733BB Q47117632-06CCB826-3396-4252-B6C2-6D7DA477079C Q51002474-FA1874FD-D0E3-4D50-A3D5-BF9CF63C80D4 Q51200743-01CCF648-6D3C-4699-8A9D-34D3902367F5 Q51598828-93D5B975-B81A-49B0-9CD7-53ECC8F9331D Q55195472-1C7598CB-DE09-449B-A0C0-2C928162967F

P2860

Diabetic kidney disease: from physiology to therapeutics

http://www.wikidata.org/entity/Q27021392

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Diabetic kidney disease: from physiology to therapeutics

@ast

Diabetic kidney disease: from physiology to therapeutics

@en

Diabetic kidney disease: from physiology to therapeutics

@nl

type

label

Diabetic kidney disease: from physiology to therapeutics

@ast

Diabetic kidney disease: from physiology to therapeutics

@en

Diabetic kidney disease: from physiology to therapeutics

@nl

prefLabel

Diabetic kidney disease: from physiology to therapeutics

@ast

Diabetic kidney disease: from physiology to therapeutics

@en

Diabetic kidney disease: from physiology to therapeutics

@nl

P1433

Q27021392-DF101F5B-1FC6-403D-A999-BD2BB5537058

P1476

Q27021392-2A3BC17B-DD4D-46D1-9888-2DAA99BCF006

P2093

Q27021392-065B026E-F413-4030-8CD0-DE2FBFD8DFFB

Q27021392-3BE023A1-69ED-4C1A-A90C-7C12A40F97BD

Q27021392-9419F9A4-5A61-4A77-ADB6-4734973658EB

Q27021392-C7674D63-6A5B-42EE-85DC-D0FDED894D82

P2860

Q27021392-03AF4612-7634-4D05-A5A4-E2CF43DA75C8

Q27021392-05BEB63C-C89B-4AC0-BA1D-DC206B3CD9F8

Q27021392-05EDA6FC-C937-4643-A8CD-8631379B8343

Q27021392-07FCF9B2-C73B-418A-A26B-768D0F7EC1BB

Q27021392-08A94A98-D26C-47D0-A82B-757599A9AF6F

Q27021392-0A1BDA0B-9369-48E2-B1F0-E5A55C2CBE69

Q27021392-0F22FB1A-1D8C-4D7F-A651-137380EBDFFE

Q27021392-0F9CE3BC-D6CC-446D-9125-A485077BBDEA

Q27021392-14BEBAFC-040D-4BA5-AAA5-6189DDDBEC92

Q27021392-16524EE0-7622-4430-B4DE-C4BA013E4840

P304

Q27021392-1E019BF8-3E84-4910-B96F-92B6774961D5

P31

Q27021392-3E9A1072-3987-44E9-9E86-B43BEDEBFD68

P3181

Q27021392-9C89B536-FB22-433C-83A5-387376E1E0A3

P356

Q27021392-70A1681C-1B27-4EE3-BAEE-DD5C242AE6B4

P407

Q27021392-155ACD91-E366-41B2-99F0-B3FAF6731E75

P433

Q27021392-DB590F61-ED1D-420E-AF43-FF9D329C710D

P478

Q27021392-D467CBB0-F0C3-4BB7-97E6-A293BE6CC1C3

P50

Q27021392-465F026B-E411-4B5B-A2A3-FC408C2809E1

Q27021392-4F778F7B-44CF-485F-92D2-58189C41993E

P577

Q27021392-6F11C5BE-7518-40FC-A735-D171CDAE7106

P5875

Q27021392-7ACE6C80-581E-4972-B9B2-58CBD6D33E1C

P698

Q27021392-6BE12570-9050-4580-996F-BCB90546F85B

P932

Q27021392-2D9ACBDE-7992-47CD-B7B8-46AB93A9F24E

P3181

P356

JPHYSIOL.2014.272328

P1433

The Journal of Physiology

P1476

Diabetic kidney disease: from physiology to therapeutics

@en

P2093

Alberto Martínez-Castelao

http://www.w3.org/2001/XMLSchema#string

José L Górriz

http://www.w3.org/2001/XMLSchema#string

Mercedes Muros de Fuentes

http://www.w3.org/2001/XMLSchema#string

Virginia Domínguez-Pimentel

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Standards of medical care in diabetes--2014

The slit diaphragm: a signaling platform to regulate podocyte function

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

P304

3997-4012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

957501

http://www.w3.org/2001/XMLSchema#string

P356

10.1113/JPHYSIOL.2014.272328

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

592

http://www.w3.org/2001/XMLSchema#string

P50

Carmen Mora-Fernández

Juan F Navarro-González

P577

2014-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262928865

http://www.w3.org/2001/XMLSchema#string

P698

24907306

http://www.w3.org/2001/XMLSchema#string

P932

4198010

http://www.w3.org/2001/XMLSchema#string